Harvard Bioscience (HBIO) Cash from Operations Growth (5y) (2015 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Intuitive Surgical | 156.17 Bn | 151.78 Bn | 1.83 Bn |
| 2 | Becton Dickinson | 41.51 Bn | 40.49 Bn | 2.15 Bn |
| 3 | Resmed | 30.43 Bn | 28.77 Bn | 890.98 Mn |
| 4 | West Pharmaceutical Services | 22.78 Bn | 22.26 Bn | 296.40 Mn |
| 5 | Solventum | 13.39 Bn | 13.39 Bn | 1.10 Bn |
| 6 | Cooper Companies | 12.33 Bn | 12.20 Bn | 695.20 Mn |
| 7 | Align Technology | 11.65 Bn | 10.59 Bn | 736.59 Mn |
| 8 | Baxter International | 9.81 Bn | 7.77 Bn | 891.00 Mn |
| 9 | Aptargroup | 7.39 Bn | 7.19 Bn | 351.91 Mn |
| 10 | Harvard Bioscience | 25.38 Mn | 18.29 Mn | 12.24 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -21.41% |
| Dec 31, 2025 | -15.31% |
| Sep 30, 2025 | -7.46% |
| Jun 30, 2025 | 3.03% |
| Mar 31, 2025 | 0.79% |
| Dec 31, 2024 | -4.92% |
| Sep 30, 2024 | -17.78% |
| Jun 30, 2024 | -26.88% |
| Mar 31, 2024 | -6.94% |
| Dec 31, 2023 | 10.66% |
| Sep 30, 2023 | 38.20% |
| Jun 30, 2023 | 22.70% |
| Mar 31, 2023 | 32.24% |
| Dec 31, 2022 | 37.15% |
| Sep 30, 2022 | -21.16% |
| Jun 30, 2022 | -19.14% |
| Mar 31, 2022 | -26.63% |
| Dec 31, 2021 | -41.63% |
| Sep 30, 2021 | -16.99% |
| Jun 30, 2021 | -4.00% |
| Mar 31, 2021 | 27.94% |
| Dec 31, 2020 | 7.14% |
| Sep 30, 2020 | 86.35% |
| Jun 30, 2020 | 47.17% |
| Mar 31, 2020 | 50.72% |
| Dec 31, 2019 | 11.94% |
| Sep 30, 2019 | 39.30% |
| Jun 30, 2019 | -14.21% |
| Mar 31, 2019 | 13.40% |
| Dec 31, 2018 | 15.73% |
| Sep 30, 2018 | -24.59% |
| Jun 30, 2018 | 9.70% |
| Mar 31, 2018 | -4.90% |
| Dec 31, 2017 | -21.68% |
| Sep 30, 2017 | -3.17% |
| Jun 30, 2017 | -28.53% |
| Mar 31, 2017 | -18.94% |
| Dec 31, 2016 | -8.16% |
| Sep 30, 2016 | 23.24% |
| Jun 30, 2016 | -10.62% |
| Mar 31, 2016 | -21.38% |
| Dec 31, 2015 | -16.12% |
| Sep 30, 2015 | -15.35% |